EGFR and non-small cell lung carcinoma: In line with results from previous studies,17 the prevalence of CTNNB1 mutations was higher in EGFR-mutated (7.7%) than in EGFR wild-type NSCLC (1.3%; χ2(1) = 36.279; P < .0001; Fig 1D).